Premium
GLT 1 overexpression reverses established neuropathic pain‐related behavior and attenuates chronic dorsal horn neuron activation following cervical spinal cord injury
Author(s) -
Falnikar Aditi,
Hala Tamara J.,
Poulsen David J.,
Lepore Angelo C.
Publication year - 2016
Publication title -
glia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.954
H-Index - 164
eISSN - 1098-1136
pISSN - 0894-1491
DOI - 10.1002/glia.22936
Subject(s) - neuropathic pain , spinal cord , medicine , glutamate receptor , spinal cord injury , chronic pain , neuroscience , astrocyte , anesthesia , central nervous system , pathology , endocrinology , biology , receptor
Development of neuropathic pain occurs in a major portion of traumatic spinal cord injury (SCI) patients, resulting in debilitating and often long‐term physical and psychological burdens. Following SCI, chronic dysregulation of extracellular glutamate homeostasis has been shown to play a key role in persistent central hyperexcitability of superficial dorsal horn neurons that mediate pain neurotransmission, leading to various forms of neuropathic pain. Astrocytes express the major CNS glutamate transporter, GLT1, which is responsible for the vast majority of functional glutamate uptake, particularly in the spinal cord. In our unilateral cervical contusion model of mouse SCI that is associated with ipsilateral forepaw heat hypersensititvity (a form of chronic at‐level neuropathic pain‐related behavior), we previously reported significant and long‐lasting reductions in GLT1 expression and functional GLT1‐mediated glutamate uptake in cervical spinal cord dorsal horn. To therapeutically address GLT1 dysfunction following cervical contusion SCI, we injected an adeno‐associated virus type 8 (AAV8)‐Gfa2 vector into the superficial dorsal horn to increase GLT1 expression selectively in astrocytes. Compared to both contusion‐only animals and injured mice that received AAV8‐eGFP control injection, AAV8‐GLT1 delivery increased GLT1 protein expression in astrocytes of the injured cervical spinal cord dorsal horn, resulting in a significant and persistent reversal of already‐established heat hypersensitivity. Furthermore, AAV8‐GLT1 injection significantly reduced expression of the transcription factor and marker of persistently increased neuronal activation, ΔFosB, in superficial dorsal horn neurons. These results demonstrate that focal restoration of GLT1 expression in the superficial dorsal horn is a promising target for treating chronic neuropathic pain following SCI. GLIA 2016;64:396–406